Daten zu öffentlichen Aufträgen und Fördermitteln in Europa aus amtlichen Registern · Datenstand: 17. November 2026, tägliche Aktualisierung.

Fördergeber · Vereinigte Staaten

National Institutes of Health

National Institutes of Health (Vereinigte Staaten): Förderprogramme (75) und Förderaufrufe (2.281), davon jetzt offen: 626 — mit Fristen und Beträgen. Datenstand: 17. November 2026, tägliche Aktualisierung.

Programme
75
Aufrufe auf der Seite
2.281
Offene Aufrufe
626

Offene Aufrufe

FörderaufrufStatusFrist
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) (Runde 11.2024 – 11.2026)Offen17. November 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) (Runde 11.2024 – 11.2026)Offen17. November 2026
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) (Runde 11.2024 – 11.2026)Offen17. November 2026
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) (Runde 11.2024 – 11.2026)Offen17. November 2026
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) (Runde 11.2024 – 11.2026)Offen17. November 2026
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) (Runde 01.2025 – 11.2026)Offen18. November 2026
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) (Runde 01.2025 – 11.2026)Offen18. November 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)Offen19. November 2026
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) (Runde 11.2024 – 11.2026)Offen19. November 2026
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)Offen23. November 2026
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) (Runde 01.2025 – 11.2026)Offen23. November 2026
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)Offen23. November 2026
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)Offen23. November 2026
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)Offen24. November 2026
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)Offen2. Dezember 2026
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) (Runde 10.2024 – 12.2026)Offen3. Dezember 2026
Emerging Global Leader Award (K43 Independent Clinical Trial Required)Offen3. Dezember 2026
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)Offen4. Dezember 2026
Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)Offen14. Dezember 2026
Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)Offen14. Dezember 2026
Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)Offen14. Dezember 2026
IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)Offen14. Dezember 2026
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) (Runde 01.2025 – 01.2027)Offen7. Januar 2027
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) (Runde 11.2024 – 01.2027)Offen7. Januar 2027
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) (Runde 11.2024 – 01.2027)Offen7. Januar 2027
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) (Runde 11.2024 – 01.2027)Offen7. Januar 2027
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) (Runde 11.2024 – 01.2027)Offen7. Januar 2027
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) (Runde 11.2024 – 01.2027)Offen7. Januar 2027
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) (Runde 10.2024 – 01.2027)Offen7. Januar 2027
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)Offen7. Januar 2027

Förderkalender